These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6113920)

  • 1. Tiotidine, a new H2-receptor antagonist, is a potent inhibitor of nocturnal acid secretion in duodenal ulcer patients.
    Valenzuela JE; Strecker RB; Douglas AP
    Dig Dis Sci; 1981 May; 26(5):433-7. PubMed ID: 6113920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotidine, a new long-acting histamine H2-receptor antagonist: comparison with cimetidine.
    Richardson CT; Feldman M; Brater C; Welborn J
    Gastroenterology; 1981 Feb; 80(2):301-6. PubMed ID: 6108895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocturnal gastric acid secretion in duodenal ulcer: inhibition by cimetidine.
    Broor SL; Shrestha GP; Mehta SK; Sharma BK
    Am J Med Sci; 1981; 282(3):120-4. PubMed ID: 6797298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H2-receptor antagonists in perspective.
    Malagelada JR; Cortot A
    Mayo Clin Proc; 1978 Mar; 53(3):184-90. PubMed ID: 24155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of etintidine in patients with duodenal ulcer.
    Brater DC; Meyers WM; Dandekar KA; Pittman KA; Peterson W
    Eur J Clin Pharmacol; 1982; 23(6):495-500. PubMed ID: 6130952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiotidine and cimetidine--kinetics and dynamics.
    Kaojarern S; Feldman M; Richardson CT; Brater DC
    Clin Pharmacol Ther; 1981 Feb; 29(2):198-202. PubMed ID: 6109588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 800 mg cimetidine once daily on gastric acid secretion.
    Dammann HG; Walter TA; Mueller P; Simon B
    Scand J Gastroenterol Suppl; 1986; 121():25-9. PubMed ID: 3532295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.
    Konturek SJ; Obtulowicz W; Kwiecien N; Sito E; Mikos E; Oleksy J
    Gut; 1980 Mar; 21(3):181-6. PubMed ID: 6105116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Famotidine in the therapy of gastric hypersecretory states.
    Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
    Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nocturnal acid secretion in duodenal ulcer patients by an H-2 histamine antagonist-cimetidine. A controlled double-blind investigation.
    Hollander D; Hossain Z; Sufi AM
    Am J Dig Dis; 1976 May; 21(6):361-5. PubMed ID: 7135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radioimmunoassay for the histamine H2-antagonist, tiotidine.
    Dobson P; Yellin TO
    Agents Actions; 1984 Oct; 15(3-4):162-6. PubMed ID: 6151804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ranitidine, a new H2-antagonist, on gastric and pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Sito E; Oleksy J; Miszczuk-Jamska B
    Dig Dis Sci; 1980 Oct; 25(10):737-43. PubMed ID: 6107221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.
    Mohammed R; Holden RJ; Hearns JB; McKibben BM; Buchanan KD; Crean GP
    Gut; 1983 Jan; 24(1):61-6. PubMed ID: 6129180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranitidine and cimetidine for duodenal ulcer.
    Langman MJ; Henry DA; Ogilvie A
    Scand J Gastroenterol Suppl; 1981 Jun; 69():115-7. PubMed ID: 6119774
    [No Abstract]   [Full Text] [Related]  

  • 16. Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer.
    Savarino V; Mela GS; Zentilin P; Bonifacino G; Moretti M; Valle F; Celle G
    Dig Dis Sci; 1989 Jul; 34(7):1043-6. PubMed ID: 2568246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine].
    Okabe S; Takeuchi K; Okada M; Kumadaki Y; Nakata M; Nakata H
    Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):133-44. PubMed ID: 2567267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response curve analysis of gastric secretory responses in the dog and man to impromidine: a new histamine-H2-receptor agonist.
    McIsaac RL; Johnston BJ; Flannery MC
    J Pharmacol Exp Ther; 1983 Apr; 225(1):186-90. PubMed ID: 6131998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effective treatment of duodenal ulcer with cimetidine (author's transl)].
    Domschke W; Domschke S; Lux G; Belohlavek D; Neidhardt B; Demling L
    Dtsch Med Wochenschr; 1976 Nov; 101(48):1752-5. PubMed ID: 11086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
    Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
    J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.